In this episode titled, Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical ...

Arch Biopartners is developing next-generation drug candidates that target IL-32, a cytokine implicated in diabetic kidney disease as described in Dr. Chun’s new publication. The goal is to produce a ...

Lioness Shetani, who spent most of her life at Dickerson Park Zoo, was euthanized Feb. 3 after her health declined due to ...

Vitamin K2 is being evaluated in helping to reduce heart disease risk, but the evidence isn’t strong enough yet to recommend it.

Struggling to lower your A1C? Learn how to identify therapeutic inertia, plus understanding diabetes progression and advocating for yourself with your treatment plan.

Explore novel therapies for IgA nephropathy that target inflammation and antibody production. Learn how these advancements ...

Collins' appointment reflects Panoramic Health's continued investment in Panoramic Science as a strategic growth engine and its commitment to building a scalable, sponsor-aligned research platform ...

Mayo Clinic researchers have developed a promising gene-editing therapy that directly corrects a genetic mutation responsible for autosomal dominant polycystic kidney disease (ADPKD), the most common ...

Arterial stiffening is strongly linked to blood pressure — but not kidney function — in children with early chronic kidney ...

An oral combination treatment may prevent the progression of advanced leiomyosarcoma, one of the most common subtypes of soft tissue sarcoma, according to a recent study published in The Lancet ...

In patients with atherosclerotic cardiovascular disease, inclisiran provides effective LDL cholesterol lowering with a ...

Chronic kidney disease (CKD) represents a significant global public health challenge, characterized by the gradual decline in renal function over time.